A global meta-analysis reported high prevalence of vancomycin-resistant Enterococcus among patients with hematological malignancies, including near-universal prevalence among stem cell transplant recipients. The scale of the pooled estimate—18.4% across 120 studies—signals persistent pressure on infection-control and antimicrobial stewardship in immunocompromised care. The analysis also underscores that resistance burden varies by subgroup, with transplant settings carrying the highest observed rates. For clinical operations, the results strengthen the case for risk-adapted infection surveillance and empiric therapy strategies tied to local resistance patterns. In parallel, additional hospital microbiology case-level reports continued to show how rare but severe infections complicate perioperative and ICU care, reinforcing the need for early recognition tools and careful diagnostic triage.